Neuropace Inc
NASDAQ:NPCE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neuropace Inc
NASDAQ:NPCE
|
US |
|
TradeDoubler AB
F:T1D
|
SE |
|
4
|
4Basebio PLC
LSE:4BB
|
UK |
|
Paradigm Biopharmaceuticals Ltd
F:P86
|
AU |
|
B
|
Bausch Health Companies Inc
F:BVF
|
CA |
|
U
|
United Internet AG
XBER:UTDI
|
DE |
|
Tamarack Valley Energy Ltd
TSX:TVE
|
CA |
|
B
|
Boosh Plant Based Brands Inc
F:77I
|
CA |
|
W
|
Western Forest Products Inc
F:NWF
|
CA |
|
T
|
Tantalus Systems Holding Inc
TSX:GRID
|
CA |
|
DREAM Unlimited Corp
TSX:DRM
|
CA |
|
A
|
Adidas AG
XMUN:ADS
|
DE |
Shareholder Yield
Current shareholder yield for NPCE is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
NPCE Price
Neuropace Inc
| Average Annual Return | 114.03% |
| Standard Deviation of Annual Returns | 313.18% |
| Max Drawdown | -95% |
| Market Capitalization | 544.2m USD |
| Shares Outstanding | 34 090 000 |
| Percentage of Shares Shorted | 3.04% |
